K181807

Substantially Equivalent

Solitaire 2 Revascularization Device, Solitaire Platinum Revascularization Device (Solitaire Revascularization Device)

Applicant: Micro Therapeutics, Inc. d/b/a ev3 Neurovascular
Product code: POL
Advisory panel: Neurology
Date received: 2018-07-06
Decision date: 2019-03-06
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Irvine, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.